Mandate

Vinge advises RusForest in connection with inter alia rights issue

September 24, 2010

RusForest carries out a rights issue amounting to approximately SEK 440 million, proposes authorisation for an issue in kind to enable acquisition of shares in companies within Nord Timber Group and acquires a majority stake in LDK-3, both companies with operations in the city of Arkhangelsk in North West Russia.

The rights issue and in kind authorisation are subject to resolutions at an extraordinary general meeting to be held on 8 October 2010 and the LDK-3 acquisition is contingent on inter alia Russian anti-monopoly approval, which is expected to be attained before the end of the year. The transactions are prompted by a capital need to facilitate the development of RusForest’s existing operations in Ust Ilimsk, Magistralny and Boguchany as well as enable RusForest’s expansion into North West Russia, which are central steps in RusForest’s development plan to become Russia’s leading independent forestry and sawmilling company.

Vinge has assisted RusForest in questions relating to Swedish law and Vinge’s team has primarily consisted of Göran Nyström, Jesper Schönbeck, Dain Nevonen, Jonas Johansson and Christian Granqvist.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026